Todd Luman

Title: Todd Luman: Innovator in Immune Cell Transduction

Introduction

Todd Luman is a prominent inventor based in Hayward, California. He has made significant contributions to the field of immunology, particularly in the area of immune cell transduction. His innovative work focuses on enhancing the efficiency of gene expression in immune cells, which has important implications for cancer therapy and other medical applications.

Latest Patents

Todd Luman holds a patent for "Methods for transducing immune cells." This patent describes improved methods for transducing immune cells, such as T cells, using retroviral vectors to express exogenous gene products, including chimeric antigen receptors (CARs). The methods outlined in the patent aim to increase transduction efficiency, thereby enhancing the percentage of immune cells in a population that express the desired exogenous gene product. The patent also covers associated cells, cell populations, compositions, and methods of use.

Career Highlights

Todd Luman is currently employed at Allogene Therapeutics, Inc., where he continues to advance his research in immune cell therapies. His work is pivotal in the development of innovative treatments that harness the power of the immune system to fight diseases.

Collaborations

Todd collaborates with notable colleagues, including Josergio Zaragoza and Abraham Germansderfer. These partnerships enhance the research and development efforts at Allogene Therapeutics, Inc., contributing to the advancement of cutting-edge therapies.

Conclusion

Todd Luman's contributions to the field of immune cell transduction exemplify the impact of innovative research on medical science. His patent and ongoing work at Allogene Therapeutics, Inc. highlight the importance of advancements in immunotherapy.